The combined value of CA125 determination and echographic ovarian imaging, in preoperative diagnosis of benign, borderline and malignant ovarian tumors

被引:0
|
作者
Stanculescu, R. [1 ]
Russu, M. [1 ]
Vladescu, T.
Bausic, V. [1 ,2 ]
Teodorescu, A. [1 ]
机构
[1] Univ Med & Pharm Carol Davila, Dept Obstet Gynecol, St Pantelimon Emergency Clin Hosp, Bucharest, Romania
[2] St Pantelimon Emergency Clin Hosp, Pathol Anat Dept, Bucharest, Romania
来源
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:311 / 313
页数:3
相关论文
共 50 条
  • [1] Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
    Huang, Ke
    Xu, Shengjie
    Wang, Jiatong
    Ge, Lili
    Xu, Juan
    Jia, Xuemei
    [J]. JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [2] Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
    Ke Huang
    Shengjie Xu
    Jiatong Wang
    Lili Ge
    Juan Xu
    Xuemei Jia
    [J]. Journal of Ovarian Research, 16
  • [3] PREOPERATIVE EVALUATION OF BORDERLINE OVARIAN TUMORS BY RISK OF MALIGNANCY INDEX, CA125 AND ULTRASOUND
    Dane, C.
    Bilgili, N.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 31 - 31
  • [4] THE CLINICAL SIGNIFICANCE OF ELEVATED PREOPERATIVE CA125 OR CA19-9 IN BORDERLINE OVARIAN TUMORS
    Song, T.
    Kim, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1677 - 1677
  • [5] THE CLINICAL SIGNIFICANCE OF ELEVATED PREOPERATIVE CA125 OR CA19-9 IN BORDERLINE OVARIAN TUMORS
    Song, T.
    Kim, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 539 - 539
  • [6] Comparison of HE4 with CA125 in differentiating malignant and benign ovarian tumors
    Shittu, K.
    Rabiu, K.
    Akinola, I
    Adewunmi, A.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 : 67 - 67
  • [7] BORDERLINE OVARIAN TUMORS - ARE THEY BENIGN OR MALIGNANT?
    Lazarou, Anastasia
    Fotopoulou, Christina
    Coumbos, Alexandra
    Sehouli, Jalid
    Vasiljeva, Jekaterina
    Braicu, Ioana
    Burger, Heinz
    Kuehn, Wolfgang
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 6257 - 6257
  • [8] CA 125 IN BORDERLINE OVARIAN TUMORS
    Uyanik, E.
    Ozten, G.
    Cetiner, S.
    Salman, M. C.
    Gultekin, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A532 - A533
  • [9] SERUM CA125 AND CA72-4 IN OVARIAN BORDERLINE TUMORS
    Lenhard, M.
    Nehring, S.
    Nagel, D.
    Mayr, D.
    Kirschenhofer, A.
    Hertlein, L.
    Friese, K.
    Stieber, P.
    Burges, A.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4033 - 4033
  • [10] PREOPERATIVE DISCRIMINATION BETWEEN BENIGN AND MALIGNANT OVARIAN-TUMORS USING A COMBINATION OF CA125 AND CA15.3 SERUM ASSAYS
    YEDEMA, C
    MASSUGER, L
    HILGERS, J
    SERVAAS, J
    POELS, L
    THOMAS, C
    KENEMANS, P
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, : 61 - 67